# A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers

Source: https://onco.cc/trials/nct07351591/  
OnCo record `nct07351591` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of the registered interventions in gallbladder cancer and other biliary tract cancers, run by Eastern Hepatobiliary Surgery Hospital, not yet recruiting.

## Summary

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers is a phase 2 interventional study registered as NCT07351591 by Eastern Hepatobiliary Surgery Hospital, with a registry enrolment figure of 88 participants, started 2026-01-30 and due to reach its primary completion in 2026-10-30. Interventions recorded: Organoid Drug Sensitivity Testing-Guided Therapy. Conditions listed: Advanced Biliary Tract Cancer(BTC). No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07351591
- Phase: 2
- Setting: Patient-Derived Tumor Organoid Drug Sensitivity Testing to Guide Treatment Selection in Patients With Unresectable Biliary Tract Cancers: A Prospective, Non-randomized, Open-label, Single-Center Phase II Clinical Trial
- Sponsor: Eastern Hepatobiliary Surgery Hospital
- Enrolled: 88

## Sources

- ClinicalTrials.gov NCT07351591: https://clinicaltrials.gov/study/NCT07351591

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07351591.json